The GLP-1 Nutrition Checklist: What to Take When You Can't Eat Enough (2026)
⚡ QUICK ANSWER
If you are on a GLP-1 medication and eating under 1,200 calories most days, you are almost certainly not getting enough protein, iron, vitamin D, or calcium from food alone. An AI-tracked dietary study of 116 semaglutide and tirzepatide users found that 88% fell below even the minimum protein recommendation, averaging just 53.8 g per day (Vinelli et al., 2026, ECO). This checklist covers the specific nutrients that drop, how much you actually need, and what to prioritize when appetite makes eating difficult.
✅ Key Takeaways
GLP-1 medications suppress appetite so effectively that most users cut intake across the board, not selectively. That proportional reduction means protein, iron, vitamin D, calcium, and B vitamins all drop in parallel. Without deliberate intervention, the resulting deficiencies drive the side effects users fear most: hair loss, muscle wasting, fatigue, and bone density decline. A targeted nutrition strategy built around a small number of high-priority nutrients can address these gaps even when total food volume stays low.
The 7 nutrients most GLP-1 patients run low on
Semaglutide, tirzepatide, and liraglutide work primarily by reducing appetite and slowing gastric emptying. The weight loss is real and often dramatic. The problem is that food intake drops proportionally, users eat less of everything, not just less junk food. A real-world dietary monitoring study tracked 116 GLP-1 users across 5,741 days of food logs and found average daily intake of just 1,102 calories and 53.8 grams of protein, compared to 1,281 calories and 62.0 grams in non-users (Vinelli et al., 2026, ECO). A separate study of 387 adults on GLP-1 therapy reported even lower numbers: 753 calories and 33.4 grams of protein per day on average, with fewer than 10% meeting recommended intakes for protein, fiber, vitamin D, calcium, or potassium (Korus et al., 2026).
A 2026 expert consensus statement from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society formally recommended integrating nutritional monitoring and individualized dietary guidance alongside GLP-1 prescriptions (Sievenpiper et al., 2026). Despite this, real-world data shows that only 5% of patients receive nutritional counseling within the first 30 days of starting treatment.
The practical consequence: if your doctor prescribed a GLP-1 and did not hand you a nutrition plan at the same time, you are in the majority. This checklist is designed to fill that gap.
How GLP-1 side effects make nutritional gaps worse
The nutritional problem is not only about eating less. GLP-1 medications create a cascade of physiological changes that compound the deficit from three directions simultaneously.
First, appetite suppression reduces total food volume. This is the intended therapeutic effect, and it works. But food is a package deal: you cannot cut calories by 30 to 40% without also cutting vitamins and minerals by a similar proportion. The Vinelli study found that the macronutrient composition of the diet did not change, GLP-1 users were not selectively avoiding protein or vegetables. They were eating less of everything, proportionally, which means every nutrient drops in lockstep with calories.
Second, gastrointestinal side effects reduce what you can tolerate. Nausea affects 15 to 20% of semaglutide users in clinical trials, and real-world reports suggest rates may be higher. Constipation, acid reflux, and bloating are also common. These symptoms discourage eating, discourage cooking, and make calorie-dense protein sources like eggs and meat less appealing. Users often gravitate toward bland, starchy foods that are low in the micronutrients they need most.
Third, delayed gastric emptying alters absorption kinetics. GLP-1 medications slow the rate at which the stomach empties into the small intestine. While this is part of the satiety mechanism, it also changes how and when nutrients are absorbed. Iron absorption, in particular, is time-sensitive and pH-dependent, and the prolonged gastric residence time may reduce efficiency. The clinical significance of this effect is still being studied, but it represents a third mechanism beyond reduced intake and reduced tolerance.
The practical implication: if you are counting only calories and ignoring nutrient density, you are missing the larger problem. On a GLP-1, every meal needs to earn its place nutritionally, because there will be fewer meals to work with.
Hair loss, muscle loss, and fatigue: the three symptoms that trace back to nutrition
When GLP-1 users search for help online, the three complaints they describe most often are hair shedding, muscle weakness, and persistent tiredness. All three link directly to the nutritional gaps listed above, each supported by published data.
Hair loss on GLP-1 medications is primarily telogen effluvium, a temporary shedding pattern triggered when the body diverts resources away from hair follicle maintenance. It typically starts two to four months after treatment begins and affects 10 to 15% of users (Neubauer et al., 2025). The metabolic stress of rapid weight loss is the primary trigger, but low ferritin, low vitamin D, low zinc, and inadequate protein each independently cause the same type of shedding, and when multiple deficiencies coexist, the effect compounds. This is why addressing nutrition is not a secondary measure for hair preservation. It is the primary intervention, alongside slowing the rate of weight loss if possible. For a complete guide to GLP-1 hair loss, including month-by-month timelines and supplement protocols, see our dedicated hair loss article.
Muscle loss during GLP-1 therapy is a subject of active clinical research. In clinical trials, lean mass accounted for roughly 25 to 40% of total weight lost, depending on the specific medication and the study population (Butsch et al., 2025). The percentage varies because it depends heavily on two modifiable factors: protein intake and resistance training. Users who maintain protein above 1.2 g/kg/day and train with progressive overload three or more days per week consistently lose less lean mass than those who do not. The 2026 multi-society expert consensus statement explicitly identified resistance exercise and protein as first-line strategies and recommended their integration from the start of GLP-1 therapy, not as an afterthought once muscle loss becomes noticeable (Sievenpiper et al., 2026).
Fatigue is the least specific of the three symptoms but often the most disruptive to daily life. It can stem from caloric deficit itself, from iron deficiency (even at ferritin levels that register as "normal" on standard lab panels), from B12 depletion, or from dehydration secondary to reduced food and fluid intake. Because fatigue has so many potential causes, the first step is always bloodwork rather than guessing. A comprehensive metabolic panel, ferritin, B12, folate, and vitamin D will identify whether the fatigue is nutritional in origin.
The checklist: 7 nutrients to monitor on GLP-1 therapy
The nutrients below are ranked by the strength of the evidence linking them to GLP-1-related deficiency and to the side effects users report most often. Each entry includes the target intake, why it matters during GLP-1 use specifically, and practical ways to reach the target when appetite is low.
1. Protein: the single most important nutrient on GLP-1
Target: 1.2 to 1.6 g per kilogram of body weight per day. For a 75 kg person, that is 90 to 120 grams daily.
Why it matters here: protein is the rate-limiting input for both muscle preservation and hair follicle maintenance, the two side effects GLP-1 users worry about most. When daily intake drops to 33 to 54 grams (which is where most users land without intervention), muscle protein synthesis stalls and follicles enter the telogen (resting) phase prematurely.
GLP-1-related weight loss can include 20 to 40% lean mass as a proportion of total weight lost if protein is not prioritized. A 2025 review in Obesity Reviews specifically recommended resistance training and adequate protein as the primary strategies for minimizing muscle loss during incretin-mimetic therapy (Mechanick et al., 2025).
Practical approaches when appetite is low: front-load protein at breakfast, when appetite tends to be least suppressed. Greek yogurt (15 to 20 grams per cup), eggs (6 grams each), and whey or collagen protein shakes (20 to 30 grams per scoop) are high-density options. Spreading protein across three or four meals rather than trying to reach the target in one sitting maximizes muscle protein synthesis response (Hector & Phillips, 2018).
2. Iron: the hair and energy nutrient most often missed
Target: ferritin above 50 ng/mL (many dermatologists recommend this threshold for hair health, even though it falls within the "normal" lab range).
Why it matters here: 64% of GLP-1 users do not meet iron intake recommendations, and over 60% fall short on calcium and iron combined. After 12 months on GLP-1 therapy, ferritin levels drop 26 to 30% compared to non-users (Urbina et al., 2026). Low ferritin independently causes telogen effluvium, the same shedding pattern triggered by rapid weight loss, compounding the hair loss risk.
Practical approach: if you are losing hair on a GLP-1, get ferritin tested before assuming it is the medication. The reason ferritin matters more than a standard hemoglobin check is timing: hemoglobin drops late in the depletion process, while ferritin reflects iron stores that begin declining months earlier. A ferritin of 25 ng/mL is technically "normal" on most lab reports but is already in the range where dermatologists see increased shedding. If your ferritin is below 50 ng/mL and you are experiencing hair loss, iron repletion is the first intervention to try: before adding biotin, before changing your dose, and before attributing the problem to the medication itself.
Chelated iron (ferrous bisglycinate) is better tolerated than ferrous sulfate, which matters considerably for users already coping with GLP-1 gastrointestinal side effects. Ferrous sulfate commonly causes constipation and nausea, two symptoms GLP-1 users are already predisposed to. Take iron with vitamin C (a glass of orange juice or a 250 mg supplement) to enhance absorption, and separate from calcium, dairy, and coffee by at least two hours, since all three inhibit iron uptake.
3. Vitamin D: the most common deficiency in GLP-1 users
Target: serum 25(OH)D of 40 to 60 ng/mL; most users need 2,000 to 4,000 IU (50 to 100 mcg) of D3 daily to reach this.
Why it matters here: vitamin D deficiency was the most frequently identified nutritional problem in GLP-1 users, affecting 13.6% at 12 months in a cohort of approximately 461,000 adults. Average intake reached only about 20% of the recommended daily amount (Urbina et al., 2026). Vitamin D is required for calcium absorption, immune function, and hair follicle cycling. Low vitamin D combined with low iron creates a compounding effect on hair loss that is worse than either deficiency alone.
Practical approach: vitamin D3 (cholecalciferol) absorbs better than D2 (ergocalciferol), and the difference is meaningful at the doses most GLP-1 users need. Take with a fat-containing meal because vitamin D is fat-soluble: absorption improves substantially when taken with even a small amount of dietary fat (eggs, avocado, olive oil, or nuts). Morning dosing with breakfast is ideal for this reason, especially since GLP-1 users often skip dinner.
Retest serum 25(OH)D after 8 to 12 weeks of supplementation to confirm you have reached the 40 to 60 ng/mL range. If you start below 20 ng/mL (frank deficiency), your doctor may recommend a loading dose of 50,000 IU weekly for 8 weeks before transitioning to a daily maintenance dose. Do not self-prescribe at this level without lab monitoring, as vitamin D is one of the few fat-soluble vitamins with a genuine toxicity risk at sustained high doses.
4. Calcium: at risk because vitamin D and food intake are both low
Target: 1,000 to 1,200 mg daily (from food plus supplement if needed).
Why it matters here: when vitamin D is low, calcium absorption drops. When food intake is low, dietary calcium drops. The combination puts bone density at risk, which matters because rapid weight loss already reduces mechanical loading on bones. A post-hoc analysis of the SURMOUNT trials found that nutritional status, including calcium, warrants monitoring during tirzepatide therapy (Almandoz et al., 2026).
Practical approach: calcium citrate is absorbed on an empty stomach, which helps when appetite is suppressed. Split into two doses of 500 to 600 mg since the body absorbs only about 500 mg at a time. Do not take at the same time as iron.
What a 1,200-calorie day with 100 g of protein looks like
The most common reaction to hearing "you need 100+ grams of protein on 1,100 calories" is that it sounds impossible. It is not, but it requires planning. Here is one example day:
| Meal | Food | Protein (g) | Calories |
|---|---|---|---|
| Breakfast | 2 eggs scrambled + 170 g Greek yogurt | 27 | 310 |
| Lunch | 120 g grilled chicken breast + mixed greens + olive oil | 36 | 350 |
| Afternoon | Whey protein shake (1 scoop) + 15 g almond butter | 25 | 250 |
| Dinner | 100 g salmon + steamed broccoli | 22 | 280 |
| Total | ~110 | ~1,190 |
The pattern: protein comes first at every eating occasion, carbohydrates and fats fill whatever caloric room is left. On days when nausea makes solid food difficult, a protein shake with collagen peptides and creatine powder can deliver 30+ grams of protein in a format most users tolerate. The key is not perfection on any single day but hitting the target across a rolling weekly average.
5. B vitamins: rising deficiency over time
Target: a B-complex that includes B12 (methylcobalamin, 500 to 1,000 mcg), B6, and folate.
Why it matters here: B vitamin deficiencies rise progressively over the course of GLP-1 therapy as reduced food intake compounds over months. Symptoms include fatigue, numbness, tingling, and cognitive fog, symptoms that overlap with GLP-1 side effects and can be mistaken for them. Semaglutide also slows gastric emptying, which can reduce B12 absorption from food.
Practical approach: sublingual B12 bypasses gut absorption entirely. A B-complex taken with the first meal of the day covers multiple B vitamins in one dose.
6. Zinc and biotin: targeted support for hair health
Target: zinc 15 to 30 mg daily (from zinc bisglycinate or picolinate); biotin 30 to 100 mcg.
Why it matters here: zinc is a cofactor in over 300 enzymatic reactions including hair follicle cell division. Biotin deficiency, while rare in well-nourished populations, becomes a genuine risk when caloric intake drops below 1,000 calories. Both are commonly included in hair-support formulas, but the evidence for biotin supplementation is strongest in confirmed deficiency rather than as a general remedy.
Practical approach: test zinc levels if possible. Take zinc with food to avoid nausea, and separate from iron. Excessive zinc (over 40 mg) can impair copper absorption.
7. Creatine: emerging evidence for muscle preservation during GLP-1 use
Target: 3 to 5 g of creatine monohydrate daily, combined with resistance training at least three days per week.
Why it matters here: GLP-1-related weight loss includes meaningful reductions in lean mass. Creatine monohydrate is the most-studied supplement for supporting muscle mass and strength during caloric restriction. A randomized controlled trial at the University of Saskatchewan (NCT07625202) is specifically testing 10 g/day creatine in people starting GLP-1 medication, combined with 12 weeks of resistance training. Results are pending, but the rationale is grounded in extensive prior evidence that creatine preserves lean tissue during energy deficits in non-GLP-1 populations.
A 2025 review in Obesity Reviews by the American Association of Clinical Endocrinology identified creatine as one of several adjuncts with potential to offset lean mass loss during incretin therapy (Mechanick et al., 2025). Creatine is not a weight loss supplement and will not make GLP-1 medications work faster. Its role here is preserving what you do not want to lose.
Practical approach: 3 to 5 g per day of creatine monohydrate, no loading phase needed. Mix into water, coffee, or a protein shake, creatine is tasteless and dissolves well in warm liquids. Timing does not matter; consistency does. Creatine monohydrate powder is the most cost-effective and best-studied form. Avoid creatine gummies unless you can verify the batch has been third-party tested for actual creatine content, as independent testing in 2025 found that several top-selling gummy brands contained little to no creatine.
One common concern: creatine draws water into muscle cells, which can temporarily increase body weight by 1 to 2 kg. On a GLP-1, where users are closely watching scale numbers, this can be discouraging. It is not fat gain, and it is not a sign the medication is failing. The water retention is intramuscular, which is actually a positive signal that creatine is reaching muscle tissue. If the scale bothers you, track body measurements and progress photos alongside weight. For more details, see our creatine during weight loss guide.
Timing and sequencing: how to fit supplements around GLP-1 side effects
GLP-1 medications commonly cause nausea, constipation, and reduced appetite, all of which make supplementation harder. The following sequence minimizes gastrointestinal conflict and maximizes absorption:
| Time | What to take | Why this timing |
|---|---|---|
| Morning, with breakfast | B-complex, vitamin D3 (with fat), creatine (in shake or coffee) | Appetite is usually least suppressed in the morning; fat-soluble vitamins need food |
| Midday, with food | Iron (with vitamin C), zinc | Separated from calcium and coffee; vitamin C enhances iron absorption |
| Evening, with or without food | Calcium citrate, magnesium | Calcium citrate absorbs without food; separated from iron by several hours; magnesium supports sleep |
On injection days, some users experience heightened nausea for 24 to 48 hours. If this is your pattern, take only the supplements you can tolerate during that window and catch up on the off-days. Consistency across the week matters more than perfection on any single day.
What about "natural GLP-1" supplements?
A growing number of supplements market themselves with the term "GLP-1" in the product name, implying they replicate the effect of semaglutide or tirzepatide. They do not. The mechanism of action is entirely different. Prescription GLP-1 receptor agonists elevate GLP-1 activity by 300,000% to 600,000% above baseline physiological levels. Supplements containing berberine, Yerba Mate, or citrus extracts may produce modest single-digit-percentage increases in endogenous GLP-1, with no published evidence showing weight loss comparable to prescription medications.
Berberine became the most visible example after TikTok labeled it "nature's Ozempic" in 2023, driving a 165% sales increase in one quarter alone. But physicians have been consistent: the weight loss magnitude is "nowhere near" what semaglutide delivers, and the gastrointestinal side effects (diarrhea, cramping) are common enough that many users discontinue within weeks. It also interacts with a range of medications including metformin, statins, and blood thinners.
At least two class-action lawsuits have been filed against supplement brands whose product names include "GLP-1," alleging that the naming misleads consumers into believing the products function like prescription drugs. One cited study showed the ingredient raised GLP-1 by 17% over four months: but "failed to show any decrease in body weight, body mass index, or waist-to-hip ratio." The fundamental problem is scale: even a 17% increase in endogenous GLP-1 is physiologically insignificant compared to the pharmacological levels generated by injectable semaglutide.
If you are currently taking a prescription GLP-1 and are considering additional supplements, focus on the documented nutrient gaps above (iron, vitamin D, protein, B vitamins, zinc) rather than on products claiming to boost GLP-1 further. Your GLP-1 levels are already elevated by orders of magnitude. What your body needs is the raw material to sustain itself through the weight loss process. For more details, see our analysis of foods and compounds that support natural GLP-1 production and our GLP-1 companion supplement review.
Five common mistakes GLP-1 users make with supplements
After reviewing the research and the patterns that show up repeatedly in user forums and clinical reports, these are the errors that undermine results most often:
Taking a generic multivitamin and assuming the gaps are covered. Most multivitamins contain 18 mg of iron and 600 IU of vitamin D: amounts designed for someone eating a full diet, not for someone on 1,100 calories a day. If your ferritin is at 25 ng/mL, 18 mg of iron daily will take months to move the needle. A targeted approach based on bloodwork is faster and more effective than a one-size-fits-all pill.
Starting supplements after hair loss is already visible. Telogen effluvium has a two-to-four-month lag: the follicles that enter the resting phase today will shed months from now. By the time you see hair in your drain, the nutritional deficit that triggered it happened weeks or months ago. Correcting iron and vitamin D at that point will help, but the shedding in progress cannot be reversed, only the next cycle of growth can be protected. Start supplementation when you start the medication, not when symptoms appear.
Prioritizing biotin over protein and iron. Biotin gets the most attention in "hair vitamin" marketing, but biotin deficiency is rare even in GLP-1 users. The nutrients that actually drive telogen effluvium (iron, vitamin D, zinc, protein) get less attention because they are less marketable. Address the nutrients that are genuinely deficient first; add biotin only if levels are confirmed low.
Skipping meals and trying to hit protein in one sitting. Muscle protein synthesis has a ceiling of roughly 30 to 40 grams per meal in most adults. Eating 90 grams of protein at dinner and nothing else captures far less of that protein for muscle building than spreading 30 grams across three meals. GLP-1 users who skip breakfast and lunch, which is common, since nausea peaks midday for many, miss two of three potential synthesis windows. Even a small protein shake in the morning counts.
Buying "GLP-1 support" products instead of addressing documented deficiencies. The supplement industry has moved fast to label products with "GLP-1" in the name. Some contain useful ingredients (vitamin D, zinc, iron). Many do not, and instead feature proprietary blends of herbs or fiber marketed with vague appetite-control claims. Read the supplement facts panel. If it does not contain the specific nutrients identified in your bloodwork, the branding is irrelevant.
When to involve your doctor
Supplementation addresses nutritional gaps. It does not replace medical monitoring. You should involve your prescribing physician or a registered dietitian if you experience any of the following: hair loss that persists past six months or worsens progressively, muscle weakness that limits daily activities, fatigue that does not improve after correcting iron and B12, numbness or tingling in hands or feet (possible B12 or neuropathy-related issue), or weight loss exceeding 1% of body weight per week for several consecutive weeks.
Ask for bloodwork before starting supplementation and again at 12 weeks. The specific labs that matter most are:
| Test | What it measures | Target for GLP-1 users |
|---|---|---|
| Ferritin | Iron storage (more sensitive than hemoglobin for detecting early depletion) | >50 ng/mL for hair health |
| Serum 25(OH)D | Vitamin D status | 40–60 ng/mL |
| Vitamin B12 | B12 status (can deplete with reduced food intake and delayed gastric emptying) | >400 pg/mL |
| Folate | B9 status | >10 ng/mL |
| Zinc | Zinc status (cofactor in hair follicle division and immune function) | 70–120 mcg/dL |
| CMP | Comprehensive metabolic panel (kidney and liver function, electrolytes) | Within reference ranges |
| Prealbumin | Short-term protein status (more responsive than albumin to recent dietary changes) | 20–40 mg/dL |
Treating confirmed deficiencies at therapeutic doses is different from taking maintenance amounts. For example, corrective iron dosing for ferritin below 30 ng/mL may require 65 mg of elemental iron daily for 8 to 12 weeks, far more than the 18 mg in a daily multivitamin. Your doctor can guide the dose and duration based on your lab results, and retest to confirm repletion before stepping down to maintenance.
Related reading
- GLP-1 and Hair Loss: Causes, Prevention, and What Helps
- GLP-1 Side Effects: What to Expect and How to Manage
- What Is GLP-1? How It Works, Medications, and Side Effects
- Creatine for Weight Loss: Does It Help You Lose Fat?
Why YourHealthier GLP-1 Companion Supplement
Our GLP-1 Companion Supplement was formulated specifically around the nutritional gaps documented in the research above. It includes chelated iron (18 mg), zinc bisglycinate (20 mg), vitamin D3 (50 mcg), biotin (5 mcg), and B12 — the nutrients most consistently found to be deficient in GLP-1 users. Every batch is third-party tested, and certificates of analysis are available on our Lab Results page.
Frequently Asked Questions
What vitamins should I take while on Ozempic or Wegovy?
Based on the 2026 Clinical Obesity review of 480,825 adults, the nutrients most commonly deficient during GLP-1 therapy are vitamin D, iron, and B vitamins (Urbina et al., 2026). A daily regimen of vitamin D3 (2,000 to 4,000 IU), chelated iron (if ferritin is below 50 ng/mL), a B-complex, and zinc addresses the most common gaps. Ask your doctor to test baseline levels before starting.
How much protein do I need on a GLP-1 medication?
Clinical guidance recommends 1.2 to 1.6 g of protein per kilogram of body weight per day during active weight loss on GLP-1 therapy. For most adults, that means 90 to 130 grams daily. Real-world data shows the average GLP-1 user consumes only 33 to 54 grams, so reaching the target requires deliberate effort: protein-first meals, shakes, and spreading intake across three or four eating occasions per day.
How do I protect muscle while losing weight on a GLP-1?
The combination of adequate protein (1.2–1.6 g/kg/day, confirmed via food diary or tracking app), resistance training at least twice weekly, and, based on emerging evidence, creatine monohydrate at 3–5 g/day may help preserve lean mass during GLP-1-mediated weight loss. A 2026 RCT (NCT07625202) is testing creatine specifically in this context. The key nutritional intervention is protein: the Vinelli 2026 data showed 88% of GLP-1 patients fell below the recommended protein threshold, making this the single most impactful correction for muscle preservation. For the full evidence on whether GLP-1 medications cause muscle loss, see our GLP-1 side effects guide.
Can I take creatine while on Ozempic or Zepbound?
There are no known drug interactions between creatine monohydrate and semaglutide, tirzepatide, or liraglutide. Creatine works by increasing phosphocreatine stores in muscle, not through GLP-1 receptor pathways. The University of Saskatchewan is running a randomized controlled trial specifically combining creatine with GLP-1 therapy (NCT07625202). If creatine causes GI discomfort, try taking it with food or splitting the dose.
Will supplements replace GLP-1 medications for weight loss?
No. Supplements address nutritional gaps that arise during GLP-1 therapy. They do not replicate the drug's mechanism of action. Products marketed as "natural GLP-1" supplements have not demonstrated comparable weight loss in any published clinical trial. Focus on nutrients your body needs, not on products claiming to replace your prescription.
How do I know if my hair loss on GLP-1 is from a nutrient deficiency?
Get bloodwork. Ferritin below 50 ng/mL, vitamin D below 30 ng/mL, and low zinc are all independent causes of telogen effluvium that compound the hair shedding from rapid weight loss. If these levels are low, correcting them with targeted supplementation can slow or reverse the shedding in most cases. For a complete guide, see our GLP-1 hair loss article.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new supplement, especially if you are taking prescription medications.
Our Batch-Level Purity Testing
Every YourHealthier product undergoes independent third-party testing at ISO 17025-accredited laboratories. We publish certificates of analysis by batch number so you can verify the exact product you purchased. View current results on our Lab Results page.
Testing & Transparency Methodology
All nutrient amounts, study data, and clinical recommendations cited in this article are sourced from peer-reviewed journals, registered clinical trials, and expert consensus statements. Each citation links directly to PubMed, ClinicalTrials.gov, or the originating news release. We do not cite retracted or predatory-journal studies. Supplement dosages reflect the ranges used in the cited research and in the 2026 multi-society consensus statement, not proprietary formulas.
References
| Source | Title | Journal |
|---|---|---|
| Urbina J et al. (2026) | Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review | Clinical Obesity |
| Korus S et al. (2026) | Dietary intake patterns and nutritional adequacy among adults treated with GLP-1 or dual GIP/GLP-1 receptor agonists — preliminary study | Journal of Translational Medicine |
| Sievenpiper JL et al. (2026) | Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies: An expert consensus statement | Obesity Pillars |
| Almandoz JP et al. (2026) | Nutritional status with tirzepatide in obesity: A post hoc analysis of the SURMOUNT-1-4 randomized clinical trials | Obesity Pillars |
| Butsch WS et al. (2025) | Nutritional deficiencies and muscle loss in adults with type 2 diabetes using glucagon-like peptide-1 receptor agonists: a retrospective observational study | Obesity Pillars |
| Mechanick JI et al. (2025) | Strategies for minimizing muscle loss during use of incretin-mimetic drugs for obesity | Obesity Reviews |
| Christensen S et al. (2024) | Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists | Obesity Pillars |
| Neubauer Z et al. (2025) | Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications | Journal of the American Academy of Dermatology |
| Rojas Lopez RF et al. (2025) | Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 Receptor Agonists | Cureus |
| Hector AJ et al. (2018) | Pronounced energy restriction with elevated protein intake results in no change in proteolysis | The FASEB Journal |
| Vinelli V et al. (2026) | AI-based monitoring of protein and nutrient intake in GLP-1 users (116 users, 5,700+ days of food logs) | European Congress on Obesity (conference) |
| Chilibeck P (ongoing) | Creatine Supplementation During GLP-1a Therapy (randomized controlled trial, 40 participants) | ClinicalTrials.gov |
Want to see YourHealthier first when you search Google? Add us as a preferred source.
Sources verified: All PubMed citations and external references in this article were last verified on October 03, 2026.
Disclosure: YourHealthier manufactures and sells the supplements discussed in this article. All health claims are based on published peer-reviewed research cited above. We earn revenue from product sales linked in this article.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
Want to see YourHealthier first when you search Google? Add us as a preferred source.